⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL27565404 | 0.96 | CA2 (0.38) | — | |
| Phosphoric Acid Monomethyl Ester SCHEMBL1478076 | 0.81 | FDPS (0.41) | — | |
| SCHEMBL5141559 | 0.80 | — | — | |
| Trimethyl Phosphate SCHEMBL1426174 | 0.77 | LMNA (0.43) | — | |
| Phosphoric Acid Monomethyl Ester SCHEMBL11316732 | 0.77 | — | — | |
| Phosphoric Acid Monomethyl Ester SCHEMBL27955495 | 0.75 | FDPS (0.50) | — | |
| Phosphoric Acid Monomethyl Ester SCHEMBL19942 | 0.75 | — | — | |
| SCHEMBL10932434 | 0.75 | — | — | |
| Methylamine SCHEMBL27838707 | 0.74 | — | — | |
| Phosphoric Acid Monomethyl Ester SCHEMBL25407716 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 245 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025245474-A1 | FORMULATIONS COMPRISING FN3-SIRNA CONJUGATES AND USES THEREOF | Aro Biotherapeutics Company (US) | 2025-11-27 | — | — | WO | claimed |
| CN-116903690-A | Nucleoside dimer, preparation method thereof and application thereof in DNA synthesis | 中国人民解放军军事科学院军事医学研究院 | 2023-10-20 | — | — | CN | claimed |
| EP-4183408-A1 | COMBINED ENTEROTOXIGENIC ESCHERICHIA COLI AND SHIGELLA RECOMBINANT | The United States of America as Represented by The Secretary of the Navy (US) | 2023-05-24 | — | — | EP | claimed |
| US-11077200-B2 | Combined enteropathogen recombinant construct | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2021-08-03 | — | — | US | claimed |
| US-20190008979-A1 | Combined enteropathogen recombinant construct | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY | 2019-01-10 | — | — | US | claimed |
| US-10105448-B2 | Combined enteropathogen recombinant construct | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2018-10-23 | — | — | US | claimed |
| EP-2539458-B1 | MULTIPLEX AMPLIFICATION REACTION METHOD FOR DETERMINATION OF CAMPYLOBACTER JEJUNI PENNER/CAPSULE TYPE | US NAVY (US) | 2018-03-14 | — | — | EP | claimed |
| EP-2790736-B1 | IN VIVO DELIVERY OF OLIGONUCLEOTIDES | ONCOIMMUNIN INC (US) | 2018-01-31 | — | — | EP | claimed |
| EP-2185189-B1 | CAPSULE COMPOSITION FOR USE AS IMMUNOGEN AGAINST CAMPYLOBACTER JEJUNI | US NAVY (US) | 2017-09-27 | — | — | EP | claimed |
| US-20170266300-A9 | Combined enteropathogen recombinant construct | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY | 2017-09-21 | — | — | US | claimed |
| EP-3188748-A1 | IMMUNOGENIC COMPOSITION AGAINST CAMPYLOBACTER JEJUNI | The United States of America as Represented by The Secretary of the Navy (US) | 2017-07-12 | — | — | EP | claimed |
| WO-2016048810-A1 | COMBINED ENTEROTOXIGENIC ESCHERICHIA COLI AND CAMPYLOBACTER JEJUNI RECOMBINANT CONSTRUCT | THE UNITED STATES OF AMERICA AS REPRESENTED BY TH SECRETARY OF THE NAVY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016022412-A1 | IMMUNOGENIC COMPOSITION AGAINST CAMPYLOBACTER JEJUNI | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2016-02-11 | — | — | WO | claimed |
| US-20150273037-A1 | Immunogenic composition against Campylobacter jejuni | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY | 2015-10-01 | — | — | US | claimed |
| US-20150258201-A1 | Combined enteropathogen recombinant construct | GUERRY PATRICIA (US) | 2015-09-17 | — | — | US | claimed |
| US-9084809-B2 | Immunogenic capsule composition for use as a vaccine component against Campylobacter jejuni | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2015-07-21 | — | — | US | claimed |
| EP-0923595-B1 | NUCLEIC ACID MEDIATED ELECTRON TRANSFER | AMERSHAM BIOSCIENCES SV CORP (US) | 2005-11-02 | — | — | EP | claimed |
| WO-2005017129-A1 | PHOSPHORAMIDE AND USES THEREOF | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2005-02-24 | — | — | WO | claimed |
| CN-1094127-C | Substituted picolyl phosphoric acid easter with insecticidal activity and its prepn. method | HUAZHONG TEACHER S UNIV (CN) | 2002-11-13 | — | — | CN | claimed |
| CN-1213664-A | Substituted picolyl phosphoric acid easter with insecticidal activity and its prepn. method | HUAZHONG TECHER S UNIV (CN) | 1999-04-14 | — | — | CN | claimed |